Pluri Inc. Debt Instrument, Face Amount
Pluri Inc. (PLUR) had Debt Instrument, Face Amount of EUR 20.00 million as of 2021-06-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes › Debt
us-gaap:DebtInstrumentFaceAmount · last filed 2024-11-12
- 2021-06-30: Debt Instrument, Face Amount 20.00M EUR.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2021-06-30 | 20.00M EUR 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |